The transcriptome of CDK4/6 inhibition - Wikidata - wikimedia - TriplyDB

The transcriptome of CDK4/6 inhibition

The transcriptome of CDK4/6 inhibition

http://www.wikidata.org/entity/Q41669833

about

The transcriptome of CDK4/6 inhibition

http://www.wikidata.org/entity/Q41669833

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The transcriptome of CDK4/6 inhibition

@en

type

label

The transcriptome of CDK4/6 inhibition

@en

prefLabel

The transcriptome of CDK4/6 inhibition

@en

P1433

Q41669833-27F45191-4F7B-4EF4-B75E-4E7FE4C1E25A

P1476

Q41669833-0DF01785-50F4-4B32-8D5F-999A4EC5999F

P2093

Q41669833-720D00F6-48E0-4564-8E8F-C940AD224A62

Q41669833-82BA7E6B-BDDC-46A2-ACEA-39E53C941EF9

P2860

Q41669833-0E239256-84F2-4F61-8F99-B44223EB9868

Q41669833-266DF8C1-7AEF-4FD6-AD23-796E856C6C7E

Q41669833-3D8F2A80-68FC-4C18-BC47-7D070DEFC38D

Q41669833-A00092DB-1C82-45E1-B183-C9B4753B7AAB

Q41669833-C71F1448-B4DC-4684-8F16-B1505C5D05DF

Q41669833-C9DE23E3-712C-466B-8D30-391536250627

Q41669833-FA3B6FE6-8960-4FB6-85CF-BB00DCCE8F83

Q41669833-FE109C4D-2509-4F23-90DD-5976A49CF3A0

P304

Q41669833-5B76CF32-8FB5-4718-8255-D53E587F3AAE

P31

Q41669833-CA640C9F-4DB0-420D-B406-94516E478734

Q41669833-ec75caea-bddb-43d8-87f0-578ee9712082

P356

Q41669833-896C1E39-6E5A-4944-B413-DB31C3552711

P433

Q41669833-1361C59F-E35E-4EC7-91FE-DB6C0D3D15DA

P478

Q41669833-120DEB7D-CD4B-4E94-90DE-C2A03DE67BD6

P577

Q41669833-157BEEEC-8AE5-4EB5-826F-E89F24D002FD

P698

Q41669833-8A7FA288-29F5-40D0-93A1-9637AE8988D3

P932

Q41669833-41D088C0-FDBA-468E-990D-80CF01F84351

P356

P1433

P1476

The transcriptome of CDK4/6 inhibition

@en

P2093

Agnieszka K Witkiewicz

http://www.w3.org/2001/XMLSchema#string

Erik S Knudsen

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting CDK4 and CDK6: From Discovery to Therapy

Proteomic analysis of pRb loss highlights a signature of decreased mitochondrial oxidative phosphorylation

Defining the transcriptional and biological response to CDK4/6 inhibition in relation to ER+/HER2- breast cancer.

Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature.

The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies.

CDK4/6 inhibition triggers anti-tumour immunity.

Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.

P304

1859-1860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/AGING.101285

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28860413

http://www.w3.org/2001/XMLSchema#string

P932

5611978

http://www.w3.org/2001/XMLSchema#string